Statins are a class of drugs commonly used to lower bad cholesterol, but can they also treat obstructive airway diseases, such as asthma?
UC Davis Health pulmonologists taking part in an NIH-funded study are exploring an innovative approach to determine whether statins may help treat obstructive airway diseases by delivering the medication via inhalation.
“Delivering statins by inhalation is a creative way to deploy a drug that has potent biological effects in pre-clinical cell-based and animal model studies,” said Amir A. Zeki, the principal investigator of the study and professor of internal medicine who specializes in pulmonary, critical care and sleep medicine. “Because oral statins do not penetrate the airway compartment at high enough levels to be effective, delivering statins directly to the lung via inhalation might achieve better local tissue drug levels, and therefore, better clinical results. This allows the use of lower drug doses to achieve efficacy while also minimizing systemic side effects.”


.jpg)
.jpg)
.jpg)

.jpg)

.jpg)
.jpg)